Carol Townsley

Dr. Carol Townsley

After Cancer Treatment Transition (ACTT) Program, Women’s College Hospital, Toronto, ON M5S 1B2, Canada

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2022 in Canadian Oncology Nursing Journal
Verified
Journal Article
Closed access
PDF file
SMShari Moura
Shari Moura
PNPatricia Nguyen
Patricia Nguyen
ABAronela Benea
Aronela Benea
CTCarol Townsley
Carol Townsley
Background: The After Cancer Treatment Transition (ACTT) program at Women’s College Hospital (Toronto) is a transitional follow-up program for patients, their families, and healthcare providers to address the broad range of post-cancer treatment and survivorship needs. This publication describes the systematic development and implementation of the ACTT program, with a focus on the advanced practice nursing (APN) role. Program Development: ACTT development required the collaboration of an APN, a general practitioner in oncology (GPO), and an inter-professional team. ACTT developers proposed a clinic structure in an ambulatory setting, linking healthcare professionals to provide post-treatment follow-up and ongoing survivorship care. Post-treatment guidelines were developed based on expert oncologist consensus, cancer site group input, and evidence-informed guidelines or best practice recommendations. Program Implementation: Initial challenges and concerns were rooted in the requirements that post-cancer treatment care was maintained and survivor needs were addressed. Cancer site groups and the inter-professional teams provided continuous feedback on processes and protocols. ACTT established a standard approach to transition patients safely and effectively out of tertiary care and, ultimately, to primary care. Current ACTT Program: ACTT delivers comprehensive post- treatment and survivorship care through close collaboration between the GPO and APN. Both roles specialize in managing late or persistent effects, cancer surveillance and prevention, and addressing psychosocial needs prior to discharge to primary care. The survivorship care plan provided by ACTT is an informative tool for both patient and primary care provider to continue post-treatment follow-ups. Future Directions: Next steps for ACTT include expanding to other cancer specialties, exploring new ways to deliver care, optimizing the transition of care, and conducting comprehensive evaluations of patient reported outcomes.

14 October 2022 in Current Oncology
Verified
Journal Article
Open access
PDF file
PNPatricia Nguyen
Patricia Nguyen
PAParsa Azizi-Mehr
Parsa Azizi-Mehr
CTCarol Townsley
Carol Townsley
AZAfshan Zahedi
Afshan Zahedi
Background: Recently published clinical pathways for management of thyroid cancer outlined the criteria for transitioning low-risk patients to primary care within one to five years from diagnosis. However, discharge patterns among endocrinologists remain heterogeneous as there lacks a consensus regarding post-treatment care for thyroid cancer patients. Objective: This study described general characteristics and outcomes of thyroid cancer patients who were discharged from specialist care and transitioned to a primary care-based follow-up clinic. Methods: Thyroid cancer patients seen in the After Cancer Treatment Transition (ACTT) clinic at Women’s College Hospital (Toronto, Canada) were included in the study. Electronic medical records were reviewed between May and October 2021 to collect patient characteristics and outcomes. Descriptive statistics were calculated. Results: The study cohort included 148 thyroid cancer patients and 76% were female. All cases were papillary thyroid cancer and most diagnoses were classified as T2 (42%), N0 (55%), M0 (91%), and stage 1 (83%). Nearly all patients (n = 147) had complete thyroidectomy. Levels of thyroglobulin and thyroglobulin antibodies (TgAb) were low overall, with only 5% of the study cohort deemed TgAb positive. Mean levels of thyroid stimulating hormone (TSH) measured at 2 time points (1.37 mIU/L, 1.42 mIU/L) were within normal range. About 91% of the study cohort had normal TSH levels and 82% met target TSH levels. There were 2 cases of recurrence; however, investigation determined that they were not initially appropriate candidates for transition to primary care. Nearly 99% (n = 146) of patients had excellent response to therapy, showed no evidence of disease recurrence, and have not required re-referral to specialist care. Conclusions: These findings may reassure specialists that low-risk, stable thyroid cancer patients can be safely transitioned to primary care for post-treatment follow-up.

8 June 2021 in Thyroid®
Verified
Journal Article
Closed access
NJNeha Janmohamed
Neha Janmohamed
PSPhillip Segal
Phillip Segal
ACAnn Marie Corrado
Ann Marie Corrado
Aisha LoftersAisha Lofters
Aisha Lofters
PNPatricia Nguyen
Patricia Nguyen
AZAfshan Zahedi
Afshan Zahedi
Background: Thyroid cancer patient discharge patterns from specialists are heterogeneous, with some specialists following patients for a longer period of time than others. With no well-established transitional plan, such as in breast and colorectal cancer, primary care physicians play a variable role in long-term thyroid cancer care. The objective of this study was to examine endocrinologist-perceived factors affecting the transition of care for thyroid cancer patients through a qualitative and quantitative survey of practicing endocrinologists in Ontario, Canada. Methods: All eligible practicing endocrinologists in Ontario were invited to participate in the study, via an email with an embedded survey link. Consent was assumed if the physician completed the survey. The survey collected physician demographics and asked a series of Likert-scale and open-ended questions on their views regarding transitioning care of their thyroid cancer patients. Quantitative analysis was based on mode and variability. Qualitative analysis was completed using inductive thematic analysis. Results: Seventy physicians completed the survey, with a response rate of 35.5%. Based on the responses to the Likert-scale questions, there was a lack of consensus in terms of discharging criteria for patients who had low-risk papillary thyroid cancer, stable thyrotropin levels, multiple nonthyroid-related comorbidities, and hemithyroidectomy with no disease recurrence. The majority of endocrinologists responded that the main factors affecting discharge included whether the primary care physician was able to follow their recommendations, whether the primary care physician could appropriately adjust levothyroxine doses, and whether the patient was confident that their primary care physician could manage their thyroid cancer follow-up. Themes extracted from the open-ended question also indicated that the main factors affecting the transition of care were related to the primary care physician, the patient, the imaging interpretation, and the discharge guidelines. Conclusion: The lack of consensus among endocrinologists affects the transition of patient care, and there is a need to provide clear and accurate information to primary care physicians and thyroid cancer patients on postcancer treatment care. Efforts should be sought to standardize discharge and long-term care.

5 February 2022 in Canadian Oncology Nursing Journal
Verified
Journal Article
Closed access
PDF file
SMShari Moura
Shari Moura
PNPatricia Nguyen
Patricia Nguyen
ABAronela Benea
Aronela Benea
CTCarol Townsley
Carol Townsley
Contexte : Le programme « After Cancer Treatment Transition » ou ACTT du Women’s College Hospital, à Toronto, est un programme de transition à l’intention des patients, des familles et des professionnels de la santé dont le but est de répondre aux nombreux besoins survenant après le traitement et en phase de survivance. Le présent article décrit l’élaboration et la mise en œuvre systématiques du programme ACTT, plus précisément, le rôle des infirmières en pratique avancée (IPA). Conception du programme : La mise en œuvre de l’ACTT requérait la collaboration d’une IPA, d’un omnipraticien en oncologie (OO) et d’une équipe interprofessionnelle. Les concepteurs de l’ACTT ont proposé d’instaurer une structure clinique dans un milieu de soins externes afin de mettre en lien les professionnels de la santé et d’arriver à fournir un suivi post-traitement et des soins continus aux survivants. L’élaboration des lignes directrices post-traitement s’est appuyée sur un consensus d’experts en oncologie, l’avis d’un groupe spécialiste de certains types de cancer, d’autres lignes directrices fondées sur la recherche ou des recommandations sur les pratiques exemplaires. Mise en œuvre du programme : Au départ, on s’inquiétait surtout de l’importance de maintenir les soins post-traitement et de répondre aux besoins des survivants. On a donc demandé aux groupes spécialistes et aux équipes interprofessionnelles de fournir leurs commentaires en continu. L’ACTT a établi une approche normalisée pour assurer aux patients une transition sûre et efficace à la fin des soins tertiaires et, en bout de ligne, les aider à obtenir des soins primaires. Programme ACTT actuel : L’ACTT fournit des soins post-traitement et des soins aux survivants complets grâce à l’étroite collaboration entre l’OO et l’IPA. Tous deux sont des spécialistes de la prise en charge des effets tardifs ou persistants, de la surveillance et de la prévention du cancer, ainsi que de la satisfaction des besoins psychosociaux avant la transition vers les soins primaires. Le plan de soins aux survivants de l’ACTT est un outil informatif pour les patients et les fournisseurs de soins primaires en vue de continuer les suivis post-traitement. Orientations futures : Il est prévu d’étendre le programme ACTT à d’autres types de cancer, d’explorer de nouvelles modalités de soins, d’optimiser le processus de transition et d’analyser en profondeur les résultats rapportés par les patients.